BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3496048)

  • 1. [Increased anti-tumor activity of chemotherapeutic agents combined with direct current against murine transplanted tumors].
    Ito H; Nakayama T; Shigematsu N; Nishiguchi I; Hashimoto S
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1854-9. PubMed ID: 3496048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor.
    Mohamed F; Stuart OA; Glehen O; Urano M; Sugarbaker PH
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):719-24. PubMed ID: 16614851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental study of the anti-tumor activity of direct current--an effective adjuvant therapy in irradiation].
    Ito H; Hashimoto S
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1405-11. PubMed ID: 2786377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
    Elliott WL; Roberts BJ; Howard CT; Leopold WR
    Cancer Res; 1994 Aug; 54(16):4412-8. PubMed ID: 8044790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing effect of new biological response modifier sulfoethylated (1-->3)-beta-D-glucan on antitumor activity of cyclophosphamide in the treatment of experimental murine leukoses.
    Khalikova TA; Korolenko TA; Zhanaeva SY; Kaledin VI; Kogan G
    Exp Oncol; 2006 Dec; 28(4):308-13. PubMed ID: 17285116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Potentiation of chemotherapeutic activity by a Chinese herb medicine juzen-taiho-toh].
    Komiyama K; Hirokawa Y; Zhibo Y; Umezawa I; Hata T
    Gan To Kagaku Ryoho; 1988 May; 15(5):1715-9. PubMed ID: 3130806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor effect of electrochemical therapy on transplantable mouse cancers.
    Wójcicki M; Droździk M; Olewniczak S; Opolski A; Wietrzyk J; Radzikowski C; Kaczmarek B; Wrzesiński M; Romanowski M; Kamiński M; Zieliński S
    Med Sci Monit; 2000; 6(3):498-502. PubMed ID: 11208360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models.
    Schmid FA; Sirotnak FM; Otter GM; DeGraw JI
    Cancer Treat Rep; 1987; 71(7-8):727-32. PubMed ID: 3607784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy.
    Mason KA; Ariga H; Neal R; Valdecanas D; Hunter N; Krieg AM; Whisnant JK; Milas L
    Clin Cancer Res; 2005 Jan; 11(1):361-9. PubMed ID: 15671567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A metronomic schedule of cyclophosphamide combined with PEGylated liposomal doxorubicin has a highly antitumor effect in an experimental pulmonary metastatic mouse model.
    Shiraga E; Barichello JM; Ishida T; Kiwada H
    Int J Pharm; 2008 Apr; 353(1-2):65-73. PubMed ID: 18155369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of tumor size on S-2-(3-aminopropylamino)ethylphosphorothioic acid and misonidazole alteration of tumor response to cyclophosphamide.
    Milas L; Ito H; Hunter N
    Cancer Res; 1983 Jul; 43(7):3050-6. PubMed ID: 6303574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of manganese superoxide dismutase reduces tumor control radiation dose: gene-radiotherapy.
    Urano M; Kuroda M; Reynolds R; Oberley TD; St Clair DK
    Cancer Res; 1995 Jun; 55(12):2490-3. PubMed ID: 7780953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.
    Mohammad RM; Wall NR; Dutcher JA; Al-Katib AM
    Clin Cancer Res; 2000 Dec; 6(12):4950-6. PubMed ID: 11156256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent, moderate-dose cyclophosphamide administration improves the efficacy of cytochrome P-450/cytochrome P-450 reductase-based cancer gene therapy.
    Jounaidi Y; Waxman DJ
    Cancer Res; 2001 Jun; 61(11):4437-44. PubMed ID: 11389073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combination therapy of local administration of OK-432 and radiation on a murine fibrosarcoma (NFSa)--combination effect and histological examination].
    Mukai M; Ando K; Koike S; Ishikawa T; Ryu M; Nagashima T; Nagao K; Isono K
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):556-62. PubMed ID: 3954378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of the thermal response of animal tumors by Corynebacterium parvum.
    Urano M; Suit HD; Dunn P; Lansdale T; Sedlacek RS
    Cancer Res; 1979 Sep; 39(9):3454-7. PubMed ID: 476675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. d,l-buthionine-(S,R)-sulfoximine potentiates in vivo the therapeutic efficacy of doxorubicin against multidrug resistance protein-expressing tumors.
    Vanhoefer U; Cao S; Minderman H; Toth K; Skenderis BS; Slovak ML; Rustum YM
    Clin Cancer Res; 1996 Dec; 2(12):1961-8. PubMed ID: 9816155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrochemical treatment of mouse and rat fibrosarcomas with direct current.
    Chou CK; McDougall JA; Ahn C; Vora N
    Bioelectromagnetics; 1997; 18(1):14-24. PubMed ID: 9125227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forphenicinol enhances the antitumor effects of cyclophosphamide in a model of squamous cell carcinoma.
    Murphy KT; Wardak A; Beckett MA; Lopez CA; Mehta N; Kimchi E; Salloum RM; Jaskowiak NT; Posner MC; Ohno T; Kufe DW; Weichselbaum RR; Mauceri HJ
    Cancer Chemother Pharmacol; 2005 Sep; 56(3):317-21. PubMed ID: 15887016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor effectiveness of different amounts of electrical charge in Ehrlich and fibrosarcoma Sa-37 tumors.
    Ciria HC; Quevedo MS; Cabrales LB; Bruzón RP; Salas MF; Pena OG; González TR; López DS; Flores JM
    BMC Cancer; 2004 Nov; 4():87. PubMed ID: 15566572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.